H.J. Res. 125 is a joint resolution that uses chapter 8 of title 5, United States Code (the Congressional Review Act, or CRA) to disapprove a Department of Health and Human Services policy titled "Policy on Adhering to the Text of the Administrative Procedure Act," which was published March 3, 2025.
The text cites a Government Accountability Office letter (Aug. 27, 2025) printed in the Congressional Record concluding that the policy qualifies as a rule under chapter 8.
If enacted, the resolution would strip that HHS policy of legal effect. Beyond the immediate nullification, invoking the CRA carries statutory consequences for whether the agency can reissue a similar rule and alters the legal and operational landscape for HHS counsel, regulated entities, and administrative-law litigation surrounding agency interpretive statements.
At a Glance
What It Does
The resolution disapproves under the Congressional Review Act the HHS "Policy on Adhering to the Text of the Administrative Procedure Act" identified by publication date and a GAO opinion, and declares the policy void. By relying on chapter 8 of title 5, it triggers the CRA framework that governs expedited congressional disapproval of agency rules.
Who It Affects
Directly affected parties include HHS leadership and counsel, federal administrative-law practitioners, health-care providers and institutions that rely on HHS interpretive guidance, and agencies considering similar policy statements. Indirectly, courts that adjudicate challenges to agency action and regulated entities adjusting compliance programs will need to account for the change.
Why It Matters
This is a straightforward use of the CRA to police an agency's interpretive policy rather than a rate-setting or substantive regulation, signaling Congress's willingness to treat certain policy statements as reviewable rules. The move can constrain how HHS (and potentially other agencies) drafts internal policy about interpreting the Administrative Procedure Act.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
H.J. Res. 125 identifies a single HHS instrument—the "Policy on Adhering to the Text of the Administrative Procedure Act"—by its publication date and a GAO letter that concluded the instrument is a rule within the meaning of chapter 8, title 5.
The joint resolution declares congressional disapproval of that specific instrument and states that it should be of no legal effect. The bill is terse: it locates the policy, cites GAO’s classification, and invokes the CRA’s disapproval mechanism.
Because the resolution acts under the Congressional Review Act, passing it would do more than cancel the named policy for the moment. Under the CRA’s framework, a disapproved rule may not be reissued in substantially the same form unless Congress authorizes it, which constrains the agency’s near-term options.
Enforcement practices, internal guidance, and how HHS advises components on applying the Administrative Procedure Act will need adjustment to reflect the absence of that policy as a binding guide within the agency.Practically, regulated parties and litigation counsel will face two immediate questions: whether actions taken while the policy was in effect remain legally defensible, and how lower-tier guidance from HHS will be treated going forward. The resolution does not itself resolve those downstream legal questions—courts will determine how to treat prior agency decisions, and HHS will need to decide whether to replace the policy with a different approach, promulgate a formal rule through notice-and-comment, or rely on less formal guidance mechanisms.Finally, the resolution is narrow in scope: it targets a named HHS policy statement and relies on GAO’s opinion for the classification that makes CRA available.
It does not amend substantive provisions of the Administrative Procedure Act or create new regulatory duties; its primary force is political and procedural—removing one instrument from the agency toolkit and signaling congressional oversight of how agencies frame interpretive commitments.
The Five Things You Need to Know
The joint resolution disapproves a named HHS instrument titled "Policy on Adhering to the Text of the Administrative Procedure Act," citing its publication date of March 3, 2025.
The text incorporates a Government Accountability Office letter dated August 27, 2025 (printed in the Congressional Record Sept. 3, 2025) that concluded the policy qualifies as a "rule" under chapter 8 of title 5.
The resolution invokes the Congressional Review Act (chapter 8, title 5) to nullify the identified HHS policy—if enacted, the policy would be treated as having no legal effect.
CRA consequences mean the disapproved policy cannot be reissued in substantially the same form except with express congressional authorization, limiting HHS’s ability to republish the same policy instrument.
H.J. Res. 125 is a single-purpose joint resolution introduced Sept. 18, 2025 (H.J. Res. 125) and referred to the House Committee on the Judiciary.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Names the HHS policy and cites GAO's classification
This opening portion identifies the exact policy being targeted by title and publication date and references the GAO letter printed in the Congressional Record that concluded the policy is a "rule" under chapter 8. Practically, that citation performs two tasks: it anchors congressional jurisdiction under the CRA and supplies the factual predicate Congress is using to justify disapproval.
Congress disapproves the named policy and removes its legal effect
The core operative sentence states that Congress disapproves the identified HHS policy and that the rule "shall have no force or effect." Legally, this is the simple nullification step available under the CRA—Congress declares the instrument void for regulatory purposes rather than proposing amendments to statutory law.
Invokes chapter 8 of title 5 (the Congressional Review Act)
By expressly relying on chapter 8, the resolution triggers the CRA’s downstream mechanics: expedited consideration procedures, the ability to block a rule from taking or retaining effect, and the statutory bar on reissuing a substantially similar rule without authorization. The resolution itself does not restate these ancillary CRA rules but invokes that body of law as the governing framework.
This bill is one of many.
Codify tracks hundreds of bills on Government across all five countries.
Explore Government in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Health-care providers and institutions that opposed the HHS policy: removing the policy may reduce the risk of new HHS-enforced interpretive constraints that could have affected compliance obligations.
- Members of Congress and oversight staff seeking to assert legislative control over agency interpretive practices: the resolution reinforces congressional oversight credibility under the CRA.
- Administrative-law litigants who challenged the policy’s legal status: nullification narrows one axis of agency authority they contested and may simplify ongoing or future litigation strategies.
Who Bears the Cost
- Department of Health and Human Services leadership and legal staff: loss of a centralized interpretive policy removes a tool for directing consistent agency action and may require reworking internal procedures or pursuing rulemaking.
- Regulated entities that had adjusted operations based on the HHS policy: they face uncertainty if the policy influenced prior compliance choices and may need to reassess past actions.
- Federal administrative law practitioners and courts: invalidation creates litigation questions about the effect of prior HHS decisions and whether reliance interests or procedural defenses remain available.
Key Issues
The Core Tension
The central dilemma is between democratic accountability—Congress exercising its statutory power under the CRA to block agency interpretive instruments—and the need for agencies to retain flexible, internal mechanisms for coherent administration; invalidating a policy promotes congressional oversight but risks creating uncertainty and procedural costs that can hinder efficient governance.
The resolution rests on a threshold classification issue: whether a policy statement that purports to set an agency’s internal approach to applying the Administrative Procedure Act is a "rule" for purposes of the CRA. GAO concluded it is; Congress is using that conclusion to proceed under chapter 8.
That sequence leaves open judicial review of both the GAO determination and any litigation over the agency’s prior reliance on the policy. The resolution itself does not resolve whether final agency actions taken while the policy was in place are invalid, which means litigation over retroactivity and reliance is likely.
Another tension is institutional: the CRA gives Congress a blunt instrument to eliminate instruments it regards as rules, but doing so can create regulatory vacuums. If HHS used the policy to coordinate consistent interpretations across components, its removal could produce short-term inconsistency and uncertainty about enforcement expectations.
Conversely, treating interpretive policies as subject to CRA scrutiny may push agencies toward formal notice-and-comment rulemaking for matters they previously handled as internal guidance, increasing procedural burdens and slowing administrative responsiveness.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.